Abstract:In this study, we aim to evaluate the anti-diabetic potential of Thunbergia mysorensis leaves methanolic extract (MeL) using inhibitory assays for α-glucosidase (AG), α-amylase (AM) (carbohydrate digestive enzymes) and aldose reductase (AR) (an enzyme involved in the polyol pathway responsible for glycation). In addition to antidiabetic studies, antioxidant studies were also performed due to the fact that reactive oxygen species (ROS) are produced by various pathways under diabetic conditions. Hyperglycemia induces ROS by activating the glycation reaction and the electron transport chain in mitochondria. The MeL effectively inhibited the enzymes (AG IC 50 : 27.86 ± 1.0, AM IC 50 : 12.00 ± 0.0, AR IC 50 : 4.50 ± 0.09 μg/mL) and showed effective radical ion scavenging activity during the antioxidant assay (DPPH EC 50 : 30.10 ± 0.75, ABTS EC 50 : 27.25 ± 1.00, Superoxide EC 50 : 35.00 ± 1.50 μg/mL). Using activity-guided repeated fractionation on a silica gel column chromatography, two compounds including 3,4-dimethoxy benzoic acid (DMBA) (101 mg) and 3,4-dimethoxy cinnamic acid (DMCA) (87 mg) with potent anti-diabetic activity were extracted from the MeL of T. mysorensis leaves. Both DMBA (IC 50 AG: 27.00 ± 1.05, IC 50 AM: 12.15 ± 0.10, IC 50 AR: 4.86 ± 0.30 μg/mL) and DMCA (IC 50 AG: 27.25 ± 0.98, IC 50 AM: 12.50 ± 0.20, IC 50 AR: 5.00 ± 1.00 μg/mL) were subjected for enzyme inhibition. Since both compounds significantly inhibited AM, enzyme kinetics for AM inhibition was performed. The compounds also showed effective antioxidant potential (DPPH EC 50 : 30.50 ± 0.99, ABTS EC 50 : 27.86 ± 0.16, Superoxide EC 50 : 36.10 ± 0.24 μg/mL), and DMCA (DPPH EC 50 : 31.00 ± 1.00, ABTS EC 50 : 28.00 ± 0.25, Superoxide EC 50 : 36.25 ± 0.37 μg/mL). Further, to elucidate the role of DMBA and DMCA in enzyme inhibition and stability at the molecular level, both compounds were subjected for in silico enzyme inhibitory studies using molecular docking simulation, molecular dynamics (MD) simulation, and binding free energy calculations. Compared to AR and AG, AM was the most significantly inhibited enzyme (DMBA: −6.6 and DMCA: −7.8 kcal/mol), and compounds combined with AM were subjected to MD simulation. Both compounds were stable in the binding pocket of AM till 100 ns and chiefly use Van der Waal's energy to bind. Compared to the controls, both DMBA and DMCA had a higher efficiency in the inhibition of target enzymes in vitro and in silico . The presence of DMBA and DMCA is more likely to be associated with the potential of MeL in antihyperglycemic activity. This bio-computational study indicates DMBA and DMCA as potential lead inhibitors of AM and could be used as effective anti-diabetic drugs in the near future. Graphical Communicated by Ramaswamy H. Sarma

Antidiabetic Potential of Abelmoschus manihot Flower Extract: In Vitro and Intracellular Studies

Enrichment and Purification of the Bioactive Flavonoids from Flower of Abelmoschus Manihot (L.) Medic Using Macroporous Resins

Effect of Abelmoschus manihot Flavone on Lipid Metabolism in Diabetic Mice

Extraction of Flavonoids from the Flowers of Abelmoschus Manihot (L.) Medic by Modified Supercritical CO2 Extraction and Determination of Antioxidant and Anti-Adipogenic Activity

Optimization of Flavonoid Extraction from Abelmoschus manihot Flowers Using Ultrasonic Techniques: Predictive Modeling through Response Surface Methodology and Deep Neural Network and Biological Activity Assessment

Chemical Profile and Potential Application of Agri-food Waste Products for Counteracting Diabetes Induced Neuropathy in Rats

Hepatoprotective and Hypoglycemic Effects of a Tannin Rich Extract from Ximenia Americana Var. Caffra Root

[Effect of flavonoids from Abelmoschus manihot on proliferation, differentiation of 3T3-L1 preadipocyte and insulin resistance]

Exploring Active Ingredients, Beneficial Effects, and Potential Mechanism of Allium tenuissimum L. Flower for Treating T2DM Mice Based on Network Pharmacology and Gut Microbiota

Traditional Medicinal Herbs and Food Plants Have the Potential to Inhibit Key Carbohydrate Hydrolyzing Enzymes In Vitro and Reduce Postprandial Blood Glucose Peaks In Vivo

Potent Antidiabetic Activity and Metabolite Profiling of Melicope Lunu-ankenda Leaves.

Potential Anti-Diabetic Benefits of Momordica charantia Extracts on Experimental Diabetes and its Complications

α-Amylase inhibitory potential of Thunbergia mysorensis leaves extract and bioactive compounds by in vitro and computational approach

Antidiabetic Activity and Chemical Composition of Sanbai Melon Seed Oil

Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy

Anticonvulsant, antidepressant-like activity of Abelmoschus manihot ethanol extract and its potential active components in vivo

Potential anti-diabetic components of Apocynum venetum L. flowers: Optimization, chemical characterization and quality evaluation

In Vitro Alpha-Amylase and Alpha-Glucosidase Inhibitory Activity and In Vivo Antidiabetic Activity of Withania frutescens L. Foliar Extract

Meliacinolin: a potent α-glucosidase and α-amylase inhibitor isolated from Azadirachta indica leaves and in vivo antidiabetic property in streptozotocin-nicotinamide-induced type 2 diabetes in mice

The potential protective effect of aqueous extract of Acanthophyllum glandulosum root on Streptozotocin-induced diabetes in mice

<i>Apios americana</i> Medik flower extract protects high-glucose-treated hepatocytes and <i>Caenorhabditis elegans</i>